Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
22 Jun 2021 |
On significant placements in financial instruments |
Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share.
|
Download |
|
29 Apr 2021 |
On business and financial situation |
The Company informs about the increase of its fill-finish capacity for the manufacture of Moderna’s COVID-19 vaccine outside the United States.
|
Download |
|
12 Apr 2021 |
On business and financial situation |
The Company releases the press release related to its participation in the manufacture of the active substance of Moderna’s COVID-19 vaccine.
|
Download |
|
02 Mar 2021 |
On business and financial situation |
The Company releases an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States
|
Download |
|
02 Mar 2021 |
On business and financial situation |
The Company releases a presentation related to an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
17 Dec 2021 |
On business and financial situation |
ROVI reports that the CHMP has issued a positive opinion on Okedi® for the treatment for schizophrenia
|
Download |
|
13 Dec 2021 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 6 December 2021 and 10 December 2021
|
Download |
|
06 Dec 2021 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 29 November 2021 and 3 December 2021
|
Download |
|
22 Nov 2021 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 15 November 2021 and 19 November 2021
|
Download |
|
16 Nov 2021 |
Liquidity and counterparty agreements |
The Company informs of the termination of the Liquidity Agreement
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
08 Jan 2018 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the fourth quarter of 2017
|
Download |
|
21 Dec 2017 |
Préstamos, créditos y avales |
ROVI and the EIB agree to sign a loan to boost research into drug administration and prolonged-release technologies
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the press release related to the nine-month period ended 30 September 2017 results
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the presentation related to the nine-month period ended 30 September 2017 results.
|
Download |
|
24 Oct 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® project.
|
Download |
Pages
